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Abstract: Cytosol fraction of spermatheca and/or the ovotestis gland from the marine snail Telescopium telescopium was
found to have antimicrobial, antiprotozoal, antifertility, and immunomodulation properties. The present experiment was
conducted to explore the biochemical nature, composition, and pharmacological properties of the cytosol fraction along
with its toxicity on the hematopoietic system in vivo. This glandular extract was analyzed and found to contain enzymes,
hormones, minerals, vitamins, and other biologically active components like higher vertebrates. The present study showed
that the extract was able to restrict the induced tumor (sarcoma-180) growth in mice concomitantly with an increased
life span of the tumor bearing mice, but without any hematopoietic toxicity. This antitumor property was thought to be
mediated immunologically as also found in other aspects of pharmacological actions of this extract; hence, it could be
developed as a potent immunomodulator to be used for various pathological conditions in general, but in cancer in
particular.
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Introduction
The marine ecosystem has been recognized as
an important source of bioactive compounds
having medicinal potential. The research on
marine natural products in the last 3 decades has
led to the discoveries of many chemically and
biologically interesting molecules (1). The major
sources of biomedical compounds obtained from

invertebrates
include
sponges
(37%),
coelenterates (21%), microorganisms (18%), algae
(9%), echinoderms (6%), tunicates (6%), molluscs
(2%), and bryozoans (1%) (2). Mollusc, one of the
most abundant marine species, yielded some
important anticancer compounds like dolastatin
(3), acharan sulphate (4), kahalalide F (5), and
kulolide (6).

* E-mail: subhasisvet@yahoo.co.in
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Telescopium telescopium, a marine mollusc (snail),
holds an interesting role for many reasons. Fascinating
previous works with the cytosol fraction of
spermatheca and/or ovotestis, a complex organ of the
marine mollusc T. telescopium, exhibited
antimicrobial (7), antiprotozoal (8), reversible
antifertility, (9) mammalian sperm agglutinating,
immobilizing, and spermicidal properties (10). The
strong immunomodulatory effect on the female
reproductive system of rats was also observed (11).
The antiserum of the spermatheca extract was found
to cross-react with the human sperm plasma
membrane, as well as with the rat testicular tissues,
respectively (12).
The crude extract of the spermatheca gland,
therefore, appeared to be inherent with
pharmacobiological
and
immunomodulatory
properties, which hypothetically could further be
employed for many pathological conditions in
general, including cancer in particular. Hence, it
seems important to analyze the biochemical nature of
this glandular extract, and study its toxicity on the
hematopoietic system and explore any other
additional pharmacobiological properties, especially
for cancer biology as marine invertebrates, in
particular molluscs, are emerging as one of the most
important sources to develop novel chemotherapeutic
agents against tumor cells.
Materials and methods
Preparation of the glandular extract:
The adult snail T. telescopium was collected from
the estuaries of the Bay of Bengal near Sagar Island
(22°19′N; 80°03′E), West Bengal, India. The outer
shell of the snail was broken carefully. The whole body
was removed from the shell and washed thoroughly
with 0.15 M phosphate buffer saline (PBS) solution,
pH 7.4. The spermatheca/ovotestis gland was
dissected out from the body and collected in a sterile
beaker containing ice cold PBS. The dissected glands
from 50 snails were homogenized collectively, and
sonicated at 4 °C for 30 s, each time with a pause of 60
s at 6 μ amplitude for 1 h. The sonicated material was
then centrifuged (15,000 rpm) at 4 °C, and the
collected supernatant was filtrated through a
membrane filter. The collected filtrate (Telescopium
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bioactive compound (TBC)) was
lyophilized, and preserved at -20 °C.

aliquoted,

Biochemical analysis of the TBC
Biochemical analysis of the TBC was performed
with commercial kits.
Identification of eluted protein by SDS-PAGE
Polyacrylamide gel electrophoresis (10%) was
performed (13) under reducing conditions and
approximately 40 μg of protein was loaded in each
lane. Molecular weight markers (Bio-Rad) were also
run in parallel.
Analysis of neutral sugar
For gas liquid chromatography, a Hewlett-Packed
5890 series II gas chromatograph with a flameionization detector was used. Resolutions were
performed with a glass column (1.8 mm × 2 mm)
containing 3% of SP-2340 on Supelcoport (100-200
mesh) at 200 °C for the alditol acetate of neutral
sugars. A recording integrator HP 3396 A (HewlettPacked) was used to determine the peak areas. The
TBC 100 μg (TBC stock solution, 1 mg/mL in distilled
water) was hydrolyzed with 2 M trifluoro acetic acid
(1) in a sealed tube at 120 °C for 1.5 h, then myoinositol was added as an internal standard. The acid
was removed by co-distillation with water by
evaporation in vacuo. The hydrolysate was then
reduced with sodium borohydride and acetylated with
acetic anhydride/pyridine (1:1; v/v) and converted
into alditol acetates (14).
Animals
In total, 72 healthy, adult Swiss mice were selected
from a breeding colony and kept under
isomanagemental conditions. The animals were
divided into 12 groups, containing 6 mice in each
group.
Transplantation of Sarcoma 180 (S-180)
Of the healthy, adult Swiss mice, 60 were selected
and developed with S-180. The present form of the S180 ascites tumor was developed by Charlotte Friend
by i.p. injection of minced S-180 tissues into the Swiss
albino mice. The ascites fluid contains about 7-10 ×
7
10 tumor cells/mL on the seventh day after tumor
transplantation. Ascites fluid was withdrawn from the
peritoneal cavity of donor tumor bearing mice, 10
days post-transplantation of tumor cells and diluted
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with sterile saline so that 1 mL of fluid contained 3.5
7
× 10 cells. In addition, 0.5 mL of this fluid containing
1.75 ×107 cells/mL was injected subcutaneously in the
lateral side of the thigh region. After 7-8 days, a tumor
was palpable in that region and considered for
experimental purpose.
Evaluation of antitumor property
The animals were divided into 10 groups,
containing 6 mice in each group. Of these 10 groups,
4 (III, IV, V, and VI) received the TBC at the dose rate
of 1, 2, 3, and 5 mg/kg body weight, respectively, as a
single dose, while the same amount was inoculated as
a multiple dose on every alternative day for 3
injections to the other 4 groups (VII, VIII, IX and X).
The first 2 groups (I and II) received normal saline as
single and multiple doses, respectively, as a placebo
like the corresponding doses for each design and
volume of the tumor (π/6 LW2 where L and W are
length and width of tumor) in all the groups were
measured and calculated (15).
Histopathological Examination of Tumor Tissue
Sections (5 μ) of the tumor tissues from 6th and 21st
day of post-transplantation and treatment groups
were prepared. All the tissue sections were processed
and stained with hematoxylin and eosin stain and

mounted with DPX. The stained sections were
observed under a light microscope (400×).
Evaluation of toxicity in hematopoietic system:
The study group (XI) received the said amount of
the TBC (3 mg/kg) as a single intraperitoneal dose,
whereas the control group (XII) was administered 1
mL of double distilled water for injection by the same
route. For the counting of total bone marrow cells, 2
mice from each group were sacrificed, the femur was
collected, and marrow cells were flushed with normal
saline and collected in a centrifuge tube after
removing the femoral condyles and trochlear. Total
leukocyte count (TLC), differential leukocyte count
(DLC) and bone marrow count were performed by
standard Giemsa staining procedure after preparing
the smear on the microscopic glass slides. All the
stained slides were observed under a microscope
(400×; 1000×) and cell counts were recorded and
analyzed.
Results
Biochemical analysis of the TBC
The TBC contains a wide range of bioactive
compounds, which are presented in Table 1.

Table 1. Biochemical analysis of the TBC.
SL. No.

Composition

Concentration

SL. No.

Composition

Concentration

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

Inorganic phosphorus
Iron
Magnesium
Copper
Lithium
Non-Protein Nitrogen
Urea
Creatinine
Cholesterol
Triglycerides
HDL
Total protein
Albumin
Globulin
Sodium
Potassium
Bicarbonate

0.96 mg/dL
212 μg/dL
10.6 mEq/L
55 ppm
0.4 mEq/L
1.7 mg/dL
12 mg/dL
0.2 mg/dL
38 mg/dL
34 mg/dL
8 mg/dL
286 mg/dL
180 mg/dL
106 mg/dL
82 mEq/L
4.5 mEq/L
12 mEq/L

18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
21

Glucose
Insulin
GGT
CPK
TSH
SGPT
SGOT
LDH
AP
ALP
Testosterone
Progesterone
Estradiol
Amylase
Lipase
Vitamin B12
CPK

25 mg/dL
6.2 μIU/mL
16.0 U/L
2.0 IU/L
0.05 μIU/mL
148 U/L
352 U/L
17 IU/L
10 U/L
179 U/L
1.75 ng/mL
5.0 ng/mL
201 pg/mL
2.0 IU/L
29.0 IU/L
1504.0 pg/mL
2.0IU/L
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Analysis of neutral sugar

Identification of eluted protein by SDS-PAGE:
SDS-PAGE of the TBC revealed that nearly 20
Coomassie blue-positive components had an
estimated molecular weight between 90 kD and 16
kD, of which 68, 64, 55, 53, 51, 46, 37, 34, and 23 kD
proteins showed major polypeptide bands; however,
90, 87, 84, 78, 72, 47, 45, 30.5, 28, 26, 24, 18, and 16 kD
proteins had minor polypeptide bands, respectively
(Figure 1).
M

66

1

2

kD

68
64
55
53
51

The neutral sugar was detected as alditol acetates
by gas liquid chromatography, and was found to
contain approximately 96% glucose as neutral sugar
(Figure 2).
Tumor growth inhibition study
In the treatment modality, different amounts of the
TBC as single intraperitoneal dose were evaluated. A
significant reduction (P < 0.5) in the tumor growth
was observed with a single dose (3 mg/kg); however,
the growth inhibition was not dose dependent (Table
2). The other doses in single and multiple designs (1
mg/kg, 2 mg/kg, and 5 mg/kg) at the initial phase
showed significant (P < 0.05) reductions in tumor
growth; however, in the later phases these growth
inhibition patterns were not as significant as the 3
mg/kg body weight dose (Tables 2 and 3). A single
intraperitoneal dose of 3 mg/kg of body weight
exhibited a constant inhibition pattern of tumor
growth concomitantly with an enhanced life span of
the tumor-bearing host (Table 4).
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Evaluation of toxicity in the hematopoietic system

37
34

Total leukocytes count (TLC)

45

The TBC, when administered intraperitoneally at
the dose rate of 3 mg/kg body weight in normal,
healthy, Swiss mice, initially the total leukocyte count
increased significantly (P < 0.05), followed by gradual
diminution; however, it maintained a significant (P <
0.05) incremental gap from the initial one (Table 5).

36

24.1

23

Differential leukocytes count (DLC)
Figure 1. Electrophoretic analysis (10% SDS-PAGE) of the TBC
(Lanes 1 and 2) showing the Coomassie blue positive
polypeptide bonds (M = Biomarker).

The differential leukocyte count did not alter
significantly in Swiss mice treated intraperitoneally
with the TBC at the dose rate of 3 mg/kg body weight
(Table 6).

Table 2. Tumor volume in single dose design on different observation days (different
superscript denotes significant difference exists at 5%).
Tumor Volume (mm3) on different days
Dose of the TBC (mg/kg)

Control (Untreated group)
1
2
3
5
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9

11

13

16

18

21

427a
214c
103b
234c
93b

455a
285b
158c
261b
214b

632a
403d
147c
233b
214b

975a
568d
153c
205b
271b

1719a
1149c
286b
228b
282b

2209a
2096e
622d
252c
492b
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TOTAL AREA = 1831E+07
NUL FACTOR = 1.0000E+00
* RUN 0
START

5

AUG 31, 1994 17:02:08

IF
2.663
3.280
3.915
4.654
6.115
8.247
9.265

PW
14.225
16.436

Glucose

19.644

STOP
Closing signal file M: SIGNAL . BNC
Storing. processed peaks to M: Q8F04A10. PRO
SIGNAL FILE: M: SIGNAL.BNC
PEAK FILE: M: Q8F04A10.PRO
AREA%
RT
3.915
4.654
6.115
8.247
9.265
14.225
19.644

AREA
22207
53325
44772
11580
12837
13922
3587197

TYPE
PV
VP
PP
VV
VP
VP
PV

WIDTH
.323
.328
.499
.564
.626
.917
1.424

AREA%
.59284
1.42358
1.19525
.30914
.34270
.37167
95.76480

TOTAL AREA = 3745838
MUT FACTOR = 1.0000E+00

Figure 2. Neutral sugar glucose present in “TBC” detected by GLC.

Table 3. Tumor volume in multiple dose design of the TBC on different groups and
observation days (different superscript denotes significant difference exists at
5%).
Tumor Volume (mm3) on different days
Dose of the TBC (mg/kg)

Control (Untreated group)
1
2
3
5

0

11

15

19

25

219.73a
d
300.67
168.31c
108.57b
200.83a

1031.17a
a
1038.41
1136.92c
690.24b
1026.99a

1768.73a
b
1630.9
b
1680
1266.81c
1600.25b

2674.18a
a
2560.75
b
2487.63
1690.97c
2328.09b

3664.95c
a
3300.37
3196.55a
2551.65b
2825.67b
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Table 4. Life span of the different groups treated with different doses of the TBC
(different superscript denotes significant difference exists at 5%).
Life span after tumor transplantation (days)
Dose of the compounds(mg/kg)
Multiple dose

Single dose

34a

37a

1

41

b

47b

2

43b

68c

3

54

c

72c

5

46b

63c

Control (Untreated group)

Table 5. Total leukocyte count on different days in intervals after inoculation with the
TBC compared with the control group (different superscript denotes significant
difference exists at 5%).
Total Leukocyte Count (× 107) in days of observations
Category

Control Group (I)
Experimental Group(II)

3

6

21

29

3.2a

3.2

3.0

3.2

4

3.0

3.2

1

b

Table 6. Differential leukocyte count on different days in intervals after inoculation with the TBC
compared with the control group.
3rd day

6th day

21st day

Category

Neutrophil
Lymphocyte
Monocyte
Eosinophil
Basophil

Study group

Control

Study group

Control

Study group

Control

77
20
1
2
0

77
21
1
1
0

78
20
1
1
0

73
24
1
2
0

77
20
1
1
1

77
19
2
2
0

Bone marrow count
Intraperitoneal inoculation with the TBC at the
same dose rate increases the bone marrow count
significantly (P < 0.05), unlike most other commonly
used chemotherapeutic drugs (Table 7).
Histopathological findings
Histopathological observations revealed that the
blood vessels and nerves were free from malignant cell
invasion after treatment with the TBC (Figures 3 and
4).
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Discussion
The present biochemical analysis revealed that the
TBC is enriched with many biologically active
compounds. The reversible antifertility effect in male
rats that was initiated by IgG fraction of antiserum
raised against spermatheca extract could be explained
by the fact that glycoprotein epitopes of rat testicular
tissue resemble those of spermatheca/ovotestis of T.
telescopium (9). However, this cross-reactivity might
suggest the presence of common sperm surface
antigenicity between the species, as well as that
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Table 7. Bone marrow count on different days in intervals after inoculation with the
TBC compared with the control group (different superscript denotes significant
difference exists at 5% level between groups).
Count in different groups (× 106/mL)
Days of observation

0 day (before treatment)
th

6 day after treatment

Control

Treated

13.5

13.7

a

14

37.75b

spermatheca extract possesses species-specific
carbohydrate sequences, which were responsible for
the initial recognition steps between these diversified
species, and that the antigen(s) was/were related
immunogenically.

Figure 3. Photomicrograph showing the section of the 21st day
post-transplantation tumor tissue in control group (HE
×100) 1. Myonecrosis. 2. intermascular space.

Figure 4. Photomicrograph showing the 21st day posttransplanted section of tumor tissue in the treatment
group (HE ×400) 1. Nerve bundle appearing completely
free from invasion. 2. Blood vessels without malignant
invasion.

Among the current interest in immune responses
and malignancy is the hope that the immune system
might be used to help cancer patients (16,17), because
both cellular and humoral immunity are important in
controlling the growth of malignant cell populations,
and that it is the interactions between them that are
most important (18).
Kinetic studies from the tumor growth, following
the administration of the compound, showed that 3
mg/kg body weight single dose schedule of the
compound significantly restricts the tumor growth in
a manner that indicates the tumor static property of
the compound. This may be due to the antiangiogenic
property of the compound rather than its direct tumor
cell killing ability; though from the available results
the exact underlying mechanism is not clear.
Additionally, it may have an immunomodulator
property without any hematopoietic toxicity as the
TBC increases the total leukocyte count, but did not
alter the differential leukocyte count. This strongly
suggests that the compound possesses a strong
immunostimulating property, which may play some
vital role in immunological control of neoplastic cell
division. This immunostimulation property is again
reconfirmed by an increased bone marrow count in
the treated group. Moreover, the TBC is able to
enhance the life span of tumor bearing hosts, which
may be the result of the inhibition of suffering, pain,
less nutritional compromise, reduced cancer
associated immunosuppression, and opportunistic
infection. Furthermore, chance of metastasis seemed
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to be reduced as the blood vessels and nerves were
found to be free of malignant cell invasion after the
TBC treatment, and possibly be the another reason
for the increased life span of the treated animals.
Therefore, this unique, novel, and crude extract
isolated from T. telescopium, which was found to have

different dimensions of pharmacological actions
many of which from immunological pathways could
be developed in the future as potent and effective
immunomodulators against various disease
conditions in general, and as an antitumor agent(s) in
particular.
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